We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Suppression of Inflammation by Recombinant Salmonella typhimurium Harboring CCL22 MicroRNA.
- Authors
Yoon, Won Suck; Ryu, Seung Rel; Lee, Seung Seok; Chae, Yang Seok; Kim, Eun Jae; Choi, Ji Hyun; Oh, Sejin; Park, Se Ho; Choung, Ji Tae; Yoo, Young; Park, Yong Keun
- Abstract
Atopic dermatitis (AD) is an inflammatory, chronically relapsing, puritic skin disorder. These syndromes result from multifactorial inheritance, with interaction between genetic and environmental factors. In particular, the macrophage-derived chemokine CCL22 is directly implicated in skin inflammatory reactions and its levels are significantly elevated in serum and correlated with disease severity in AD. We tested the suppression of the CCL22 gene by microRNA (miRNA) and observed the effects in mice with inflammation similar to AD. We used Salmonella as a vector to deliver miRNA. The recombinant strain of Salmonella typhimurium expressing CCL22 miRNA (ST-miRCCL22) was prepared for in vivo knockdown of CCL22. ST-miRCCL22 was orally inoculated into mice and the CCL22 gene suppressed with CCL22 miRNA in the activated lymphocytes. IgE and interleukin-4 were inhibited and interferon-γ was induced after treatments with ST-miRCCL22 and CCL22 was suppressed. Further, Th17 cells were suppressed in the atopic mice treated with ST-miRCCL22. These results suggested that suppression of the CCL22 gene using Salmonella induced anti-inflammatory effects.
- Subjects
ATOPIC dermatitis; SKIN diseases; CHEMOKINES; SALMONELLA typhimurium; LABORATORY mice; SALMONELLA; ANTI-inflammatory agents; DIAGNOSIS; THERAPEUTICS
- Publication
DNA & Cell Biology, 2012, Vol 31, Issue 3, p289
- ISSN
1044-5498
- Publication type
Article
- DOI
10.1089/dna.2010.1118